Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SSRI' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 208 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hirose, S
      Restlessness related to SSRI withdrawal

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    2. Overall, KL
      Pharmacological treatment in behavioural medicine: The importance of neurochemistry, molecular biology and mechanistic hypotheses

      VETERINARY JOURNAL
    3. Yamato, H; Kannari, K; Shen, H; Suda, T; Matsunaga, M
      Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum?

      NEUROREPORT
    4. Venault, P; Rudrauf, D; Lepicard, EM; Berthoz, A; Jouvent, R; Chapouthier, G
      Balance control and posture in anxious mice improved by SSRI treatment

      NEUROREPORT
    5. Jensen, JB; Mork, A; Mikkelsen, JD
      Chronic antidepressant treatments decrease pro-opiomelanocortin mRNA expression in the pituitary gland: Effects of acute stress and 5-HT1A receptor activation

      JOURNAL OF NEUROENDOCRINOLOGY
    6. Brosen, K; Naranjo, CA
      Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    7. Kantor, S; Graf, M; Anheuer, ZE; Bagdy, G
      Rapid desensitization of 5-HT1A receptors in Fawn-Hooded rats after chronic fluoxetine treatment

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    8. Dulchin, MC; Oquendo, MA; Malone, KM; Ellis, SP; Li, SH; Mann, JJ
      Prolactin response to dl-fenfluramine challenge before and after treatmentwith paroxetine

      NEUROPSYCHOPHARMACOLOGY
    9. Martinez, D; Hwang, DR; Mawlawi, O; Slifstein, M; Kent, J; Simpson, N; Parsey, RV; Hashimoto, T; Huang, YY; Shinn, A; Van Heertum, R; Abi-Dargham, A; Caltabiano, S; Malizia, A; Cowley, H; Mann, JJ; Laruelle, M
      Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: A dose-occupancy study with [C-11]WAY 100635 and positron emission tomography in humans

      NEUROPSYCHOPHARMACOLOGY
    10. Hervas, I; Vilaro, MT; Romero, L; Scorza, MC; Mengod, G; Artigas, F
      Desensitization of 5-HT1A autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635

      NEUROPSYCHOPHARMACOLOGY
    11. Elfving, B; Bjornholm, B; Ebert, B; Knudsen, GM
      Binding characteristics of selective serotonin reuptake inhibitors with relation to emission tomography studies

      SYNAPSE
    12. Kirby, D; Ames, D
      Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    13. Nordeng, H; Lindemann, R; Perminov, KV; Reikvam, A
      Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors

      ACTA PAEDIATRICA
    14. Jacobs, ES; Dickstein, DP; Liebelt, EL
      Novel psychotropic medications in children: New toxicities to master

      PEDIATRIC EMERGENCY CARE
    15. Berggren, U; Eriksson, M; Fahlke, C; Balldin, J
      Relationship between central serotonergic neurotransmission and reduction in alcohol intake by citalopram

      DRUG AND ALCOHOL DEPENDENCE
    16. Meijer, WEE; Heerdink, ER; Pepplinkhuizen, LP; van Eijk, JT; Leufkens, HGM
      Prescribing patterns in patients using new antidepressants

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    17. Kameda, K; Tanaka, T; Miura, J; Kusumi, I; Koyama, T
      Effects of acute citalopram treatment on the methamphetamine-induced locomotor activity

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    18. Rilke, O; Will, K; Jahkel, M; Oehler, J
      Behavioral and neurochemical effects of anpirtoline and citalopram in isolated and group housed mice

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    19. Ekselius, L; von Knorring, L
      Effect on sexual function of kong-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    20. Ranganathan, R; Sawin, ER; Trent, C; Horvitz, HR
      Mutations in the Caenorhabditis elegans serotonin reuptake transporter MOD-5 reveal serotonin-dependent and -independent activities of fluoxetine

      JOURNAL OF NEUROSCIENCE
    21. Haddad, PM; Devarajan, S; Dursun, SM
      Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'

      JOURNAL OF PSYCHOPHARMACOLOGY
    22. Pezzella, G; Moslinger-Gehmayr, R; Contu, A
      Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline

      BREAST CANCER RESEARCH AND TREATMENT
    23. Hegerl, U; Gallinat, J; Juckel, G
      Event-related potentials - Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?

      JOURNAL OF AFFECTIVE DISORDERS
    24. Thase, ME
      The need for clinically relevant research on treatment-resistant depression

      JOURNAL OF CLINICAL PSYCHIATRY
    25. Dewa, CS; Hoch, JS; Goering, P
      Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures

      CLINICAL THERAPEUTICS
    26. Newman-Tancredi, A; Chaput, C; Touzard, M; Millan, MJ
      Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors: a [S-35]GTP gamma S autoradiography study

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    27. Muraki, I; Inoue, T; Hashimoto, S; Izumi, T; Ito, K; Koyama, T
      Effect of subchronic lithium treatment on citalopram-induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex

      JOURNAL OF NEUROCHEMISTRY
    28. Steimer, W; Muller, B; Leucht, S; Kissling, W
      Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy

      CLINICA CHIMICA ACTA
    29. Pariante, CM; Makoff, A; Lovestone, S; Feroli, S; Heyden, A; Miller, AH; Kerwin, RW
      Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

      BRITISH JOURNAL OF PHARMACOLOGY
    30. Huber, R; Panksepp, JB; Yue, Z; Delago, A; Moore, P
      Dynamic interactions of behavior and amine neurochemistry in acquisition and maintenance of social rank in crayfish

      BRAIN BEHAVIOR AND EVOLUTION
    31. Cremers, TIFH; Wiersma, LJ; Bosker, FJ; den Boer, JA; Westerink, BHC; Wikstrom, HV
      Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?

      BIOLOGICAL PSYCHIATRY
    32. Kaye, WH; Nagata, T; Weltzin, TE; Hsu, LG; Sokol, MS; McConaha, C; Plotnicov, KH; Weise, J; Deep, D
      Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa

      BIOLOGICAL PSYCHIATRY
    33. Bruder, GE; Stewart, JW; Tenke, CE; McGrath, PJ; Leite, P; Bhattacharya, N; Quitkin, FM
      Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant

      BIOLOGICAL PSYCHIATRY
    34. Grant, MM; Weiss, JM
      Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity

      BIOLOGICAL PSYCHIATRY
    35. Rapaport, MH; Wolkow, R; Rubin, A; Hackett, E; Pollack, M; Ota, KY
      Sertraline treatment of panic disorder: results of a long-term study

      ACTA PSYCHIATRICA SCANDINAVICA
    36. Murck, H; Frieboes, RM; Antonijevic, IA; Steiger, A
      Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy men

      PSYCHOPHARMACOLOGY
    37. Oerther, S; Ahlenius, S
      Involvement of 5-HT1A and 5-HT1B receptors for citalopram-induced hypothermia in the rat

      PSYCHOPHARMACOLOGY
    38. Dekeyne, A; Iob, L; Millan, MJ
      Following long-term training with citalopram, both mirtazapine and mianserin block its discriminative stimulus properties in rats

      PSYCHOPHARMACOLOGY
    39. De Marchi, N; Daniele, F; Ragone, MA
      Fluoxetine in the treatment of Huntington's disease

      PSYCHOPHARMACOLOGY
    40. Ruth, U; Mayer-Rosa, J; Schlamp, D; Freisleder, FJ
      Tourette's syndrome and antidepressant therapy: Exacerbation of nervous tics by paroxetine

      ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE
    41. Balfour, JAB; Jarvis, B
      Venlafaxine extended-release - A review of its clinical potential in the management of generalised anxiety disorder

      CNS DRUGS
    42. Nurnberg, HG; Hensley, PL; Lauriello, J
      Sildenafil in the treatment of sexual dysfunction induced by selective serotonin reuptake inhibitors - An overview

      CNS DRUGS
    43. Ereshefsky, L; Dugan, D
      Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: Focus on venlafaxine

      DEPRESSION AND ANXIETY
    44. Beech, MJ
      Sertraline-induced hypomania presenting as hyperactivity disorder

      JOURNAL OF PAEDIATRICS AND CHILD HEALTH
    45. Buitelaar, JK; Willemsen-Swinkels, SHN
      Medication treatment in subjects with autistic spectrum disorders

      EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
    46. Cowen, PJ
      Psychopharmacology of 5-HT1A receptors

      NUCLEAR MEDICINE AND BIOLOGY
    47. Martinez, D; Mawlawi, O; Hwang, DR; Kent, J; Simpson, N; Parsey, RV; Hashimoto, T; Slifstein, M; Huang, YY; Van Heertum, R; Abi-Dargham, A; Caltabiano, S; Malizia, A; Cowley, H; Mann, JJ; Laruelle, M
      Positron emission tomography study of pindolol occupancy of 5-HT1A receptors in humans: Preliminary analyses

      NUCLEAR MEDICINE AND BIOLOGY
    48. Sills, TL; Greenshaw, AJ; Baker, GB; Fletcher, PJ
      Subchronic fluoxetine treatment induces a transient potentiation of amphetamine-induced hyperlocomotion: possible pharmacokinetic interaction

      BEHAVIOURAL PHARMACOLOGY
    49. Katona, C
      Managing depression and anxiety in the elderly patient

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    50. Kameda, K; Kusumi, I; Suzuki, K; Miura, J; Sasaki, Y; Koyama, T
      Effects of citalopram on dopamine D2 receptor expression in the rat brain striatum

      JOURNAL OF MOLECULAR NEUROSCIENCE
    51. Taber, MT; Kinney, GG; Pieschl, RL; Yocca, FD; Gribkoff, VK
      Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: Sensitivity to sequence of injections

      SYNAPSE
    52. Millan, MJ; Newman-Tancredi, A; Audinot, V; Cussac, D; Lejeune, F; Nicolas, JP; Coge, F; Galizzi, JP; Boutin, JA; Rivet, JM; Dekeyne, A; Gobert, A
      Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT1B, 5-HT1D and dopamine D-2 and D-3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states

      SYNAPSE
    53. Tesei, S; Antonini, A; Canesi, M; Zecchinelli, A; Mariani, CB; Pezzoli, G
      Tolerability of paroxetine in Parkinson's disease: A prospective study

      MOVEMENT DISORDERS
    54. Harvey, BH; Bouwer, CD
      Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitors

      CLINICAL NEUROPHARMACOLOGY
    55. Michelson, D; Amsterdam, J; Apter, J; Fava, M; Londborg, P; Tamura, R; Pagh, L
      Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment

      PSYCHONEUROENDOCRINOLOGY
    56. Barbenel, DM; Yusufi, B; O'Shea, D; Bench, CJ
      Mania in a patient receiving testosterone replacement post-orchidectomy taking St John's wort and sertraline

      JOURNAL OF PSYCHOPHARMACOLOGY
    57. Silver, H; Barash, I; Aharon, N; Kaplan, A; Poyurovsky, M
      Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    58. Ekselius, L; Bengtsson, F; von Knorring, L
      Non-compliance with pharmacotherapy of depression is associated with a sensation seeking personality

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    59. Hawley, CJ; Loughlin, PJ; Quick, SJ; Gale, TM; Sivakumaran, T; Hayes, J; McPhee, S
      Efficacy, safety and tolerability of combined administration of lithium and selective serotonin reuptake inhibitors: a review of the current evidence

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    60. Murphy, TK; Bengtson, MA; Tan, JY; Carbonell, E; Levin, GM
      Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    61. Sundstrom-Poromaa, I; Bixo, M; Bjorn, I; Nordh, O
      Compliance to antidepressant drug therapy for treatment of premenstrual syndrome

      JOURNAL OF PSYCHOSOMATIC OBSTETRICS AND GYNECOLOGY
    62. Brunello, N; den Boer, JA; Judd, LL; Kasper, S; Kelsey, JE; Lader, M; Lecrubier, Y; Lepine, JP; Lydiard, RB; Mendlewicz, J; Montgomery, SA; Racagni, G; Stein, MB; Wittchen, HU
      Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment

      JOURNAL OF AFFECTIVE DISORDERS
    63. Fava, M; Rosenbaum, JF; Hoog, SL; Tepner, RG; Kopp, JB; Nilsson, ME
      Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression

      JOURNAL OF AFFECTIVE DISORDERS
    64. Pettinati, HM; Volpicelli, JR; Kranzler, HR; Luck, G; Rukstalis, MR; Cnaan, A
      Sertraline treatment for alcohol dependence: Interactive effects of medication and alcoholic subtype

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    65. Gobert, A; Dekeyne, A; Millan, MJ
      The ability of WAY100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289, but notBRL15572

      NEUROPHARMACOLOGY
    66. Hegerl, U; Moller, HJ
      Pharmacotherapy of depression in oldage

      NERVENARZT
    67. Figgitt, DP; McClellan, KJ
      Fluvoxamine - An updated review of its use in the management of adults with anxiety disorders

      DRUGS
    68. Diler, RS; Avci, A
      Open-label trial of paroxetine in children with obsessive-compulsive disorder

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    69. Duxon, MS; Starr, KR; Upton, N
      Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT1A receptor antagonist WAY100635

      BRITISH JOURNAL OF PHARMACOLOGY
    70. Kalia, M; O'Callaghan, JP; Miller, DB; Kramer, M
      Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry

      BRAIN RESEARCH
    71. Zhang, YH; Raap, DK; Garcia, F; Serres, F; Ma, Q; Battaglia, G; Van de Kar, LD
      Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats

      BRAIN RESEARCH
    72. Hollander, E; DeCaria, CM; Finkell, JN; Begaz, T; Wong, CM; Cartwright, C
      A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling

      BIOLOGICAL PSYCHIATRY
    73. Sprouse, J; Braselton, J; Reynolds, L
      5-HT1A agonist potential of pindolol: Electrophysiologic studies in the dorsal raphe nucleus and hippocampus

      BIOLOGICAL PSYCHIATRY
    74. Yamada, M; Yamada, M; Yamazaki, S; Takahashi, K; Nishioka, G; Kudo, K; Ozawa, H; Yamada, S; Kiuchi, Y; Kamijima, K; Higuchi, T; Momose, K
      Identification of a novel gene with RING-H2 finger motif induced after chronic antidepressant treatment in rat brain

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    75. Perdrizet-Chevallier, C; Membrey, JM; Dassonville, V; Leibovici, A
      Premenstrual dysphoria. A distinct clinical entity: diagnosis, classification and new treatment approach

      ANNALES MEDICO-PSYCHOLOGIQUES
    76. Mendlewicz, J; Lecrubier, Y
      Antidepressant selection: Proceedings from a TCA/SSRI Consensus Conference

      ACTA PSYCHIATRICA SCANDINAVICA
    77. Montgomery, SA; Judge, R
      Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors

      ACTA PSYCHIATRICA SCANDINAVICA
    78. Peretti, S; Judge, R; Hindmarch, I
      Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors

      ACTA PSYCHIATRICA SCANDINAVICA
    79. Emslie, G; Judge, R
      Tricyclic antidepressants and selective serotonin reuptake inhibitors: useduring pregnancy, in children/adolescents and in the elderly

      ACTA PSYCHIATRICA SCANDINAVICA
    80. Hirschfeld, RMA
      Antidepressants in long-term therapy: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors

      ACTA PSYCHIATRICA SCANDINAVICA
    81. Zohar, J; Westenberg, HGM
      Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors

      ACTA PSYCHIATRICA SCANDINAVICA
    82. Demyttenaere, K; Haddad, P
      Compliance with antidepressant therapy and antidepressant discontinuation symptoms

      ACTA PSYCHIATRICA SCANDINAVICA
    83. Donoghue, J
      Antidepressant use patterns in clinical practices: comparisons among tricyclic antidepressants and selective serotonin reuptake inhibitors

      ACTA PSYCHIATRICA SCANDINAVICA
    84. Crown, WH
      Economic outcomes associated with tricyclic antidepressant and selective serotonin reuptake inhibitor treatments for depression

      ACTA PSYCHIATRICA SCANDINAVICA
    85. Arborelius, L; Linner, L; Wallsten, C; Ahlenius, S; Svensson, TH
      Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo

      PSYCHOPHARMACOLOGY
    86. Johnson, BA; Ait-Daoud, N
      Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

      PSYCHOPHARMACOLOGY
    87. To, CT; Anheuer, ZE; Bagdy, G
      Effects of acute and chronic fluoxetine treatment on CRH-induced anxiety

      NEUROREPORT
    88. Montgomery, SA
      Social phobia: diagnosis, severity and implications for treatment

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    89. Smith, DF
      Neuroimaging of serotonin uptake sites and antidepressant binding sites inthe thalamus of humans and 'higher' animals

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    90. Smith, DF; Gee, AD; Hansen, SB; Moldt, P; Nielsen, EO; Scheel-Kruger, J; Gjedde, A
      Uptake and distribution of a new SSRI, NS2381, studied by PET in living porcine brain

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    91. Mos, J; Mollet, I; Tolboom, JTBM; Waldinger, MD; Olivier, B
      A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    92. Dong, JM; De Montigny, C; Blier, P
      Assessment of the serotonin reuptake blocking property of YM992: Electrophysiological studies in the rat hippocampus and dorsal raphe

      SYNAPSE
    93. Cummings, JL; Masterman, DL
      Depression in patients with Parkinson's disease

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    94. Hawley, CJ; McPhee, S; Gale, TM; Walker, M; Echlin, D; Sivakumaran, T
      Is it possible to measure differences in the cost of antidepressant overdoses?

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    95. Rogde, S; Hilberg, T; Teige, B
      Fatal combined intoxication with new antidepressants. Human cases and an experimental study of postmortem moclobemide redistribution

      FORENSIC SCIENCE INTERNATIONAL
    96. Wilson, AA; Houle, S
      Radiosynthesis of carbon-11 labelled N-methyl-2-(arylthio)benzylamines: Potential radiotracers for the serotonin reuptake receptor.

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    97. Acton, PD; Mu, M; Plossl, K; Hou, C; Siciliano, M; Zhuang, ZP; Oya, S; Choi, SR; Kung, HF
      Single-photon emission tomography imaging of serotonin transporters in thenonhuman primate brain with [I-123]ODAM

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    98. Ferguson, CP; La Via, MC; Crossan, PJ; Kaye, WH
      Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?

      INTERNATIONAL JOURNAL OF EATING DISORDERS
    99. Goldstein, DJ; Wilson, MG; Ascroft, RC; Al-Banna, M
      Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression

      INTERNATIONAL JOURNAL OF EATING DISORDERS
    100. Greenblatt, DJ; Von Moltke, LL; Harmatz, JS; Shader, RI
      Human cytochromes and some newer antidepressants: Kinetics, metabolism, and drug interactions

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/02/20 alle ore 21:01:54